Société de recherche sur le cancer

 
 
 
402 - 625, avenue du Président-Kennedy
Montréal, Québec
Canada
H3A 3S5
Sigle : CRS
Adresse Internet : http://www.cancer-research-society.ca

  Programme(s) de recherche actif(s)

  Projet(s) actif(s)
    Acetylation of the breast cancer suppressors BRCA1, BRCA2 and PALB2: from functional insights to an anti-cancer approach.
    Bromodomain and extra-terminal (BET) proteins, novel therapeutic targets in melanoma
    Characterization of the role of the Yin Yang1 (YY1) transcription factor in pleuropulmonary blastoma
    Deciphering the role of KLF5 and NFYA in prostate cancer
    Discovery and validation of ubiquitin-associated mutations in the DNA-damage response pathway in breast cancer
    Effects of the Leucocytic Infiltration of Intraductal Carcinoma of the Prostate
    Identification of dysregulated sphingolipids in lung cancer
    Identifier les caractéristiques définissant les cellules tumorales qui favorisent le caractère envahissant
    Interaction between environment, diet, physical activities, and sexual habits, in the risk of prostate cancer. Validation of biomarkers to personnalize preventive interventions.
    Pharmacogene methylation profiling during acute lymphoblastic leukemia treatment
    Sex steroids as modulators of the prostate cancer immune microenvironment
    The role of differential cell contractility mediated by Tissue Transglutaminase 2 in regulating the crosstalk between extracellular matrix stiffness and EGF
www.ulaval.ca